Results 181 to 190 of about 44,747 (232)

Use of hydroxychloroquine to treat patients with IgA nephropathy and time to accelerated glucocorticoid tapering. [PDF]

BMC Nephrol
Ma M, Luo Q, Huang M, Chen L, Liang W, Zhong Y, Liu F, Guan B.   +7 more
europepmc   +1 more source

Bilateral vision loss as first clinical manifestation of IgA nephropathy. [PDF]

BMC Ophthalmol
Premi E, Mambretti M, Mazzola M, Donati S.   +3 more
europepmc   +1 more source

Lipidomic profiling reveals medium-chain acylcarnitines alterations as metabolic signatures in IgA nephropathy. [PDF]

BMC Nephrol
Cheng J, Han Y, Zhang Y, He X, Zou S, She W, Peng Z, Huang L, Huang H.   +8 more
europepmc   +1 more source

Early Experience With Iptacopan for Recurrent IgA Nephropathy After Kidney Transplantation. [PDF]

Kidney Med
Al Jurdi A, Cohen Bucay A, Nissaisorakarn P, Gilligan H, Avillach CT, Klepeis VE, Smith RN, Palsson R, Safa K, Riella LV.   +9 more
europepmc   +1 more source

Nephron Number and Kidney Outcomes in IgA Nephropathy: A Retrospective Cohort Study. [PDF]

Kidney360
Marumoto H, Sasaki T, Tsuboi N, D'Agati VD, Okabayashi Y, Haruhara K, Kanzaki G, Kanzaki G, Koike K, Bertram JF, Ninomiya T, Yokoo T.   +11 more
europepmc   +1 more source

Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitis. [PDF]

CEN Case Rep
Iwami S, Eriguchi M, Kosugi T, Furuyama R, Kitamura S, Tanabe K, Matsui M, Samejima KI, Tsuruya K.   +8 more
europepmc   +1 more source

IgA Nephropathy: An Overview of the Clinical Trials. [PDF]

Kidney Med
Gholizadeh Ghozloujeh Z, Selvaskandan H, Wiegley N, Lerma E, Gaytan J, Garcia-Rivera A, Abdipour A, Norouzi S.   +7 more
europepmc   +1 more source